Clinical trials
Recruiting Phase 1/2 Leukemia, Myelomonocytic, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| M.D. Anderson Cancer Center | 3 |
| Aptose Biosciences Inc. | 1 |
| Douglas Tremblay | 1 |
| Ellipses Pharma | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Uma Borate | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 12 |
| Leukemia, Myeloid, Acute | 7 |
| Myelodysplastic Syndromes | 5 |
| Leukemia, Biphenotypic, Acute | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Myelodysplastic-Myeloproliferative Diseases | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Hematologic Neoplasms | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Lymphoid | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.